GAINESVILLE, Fla. – December 1, 2009 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the full-market release of the Oralife™ family of bone grafting products. Oralife products are an extension to the dental biologics product line and include DBM, cancellous particulate and cortical particulate. Oralife allografts may be used in clinical situations where human allograft is appropriate, such as periodontal defects and sinus grafting procedures, extraction sockets, intrabony defects and in conjunction with dental implant placement. All Oralife products are single donor grafts that are recovered and processed under AATB guidelines using Allowash^® Technology. These products are aseptically-processed human allografts that are pre- and post-processing microbial tested.